Get the Stockscreener App
495.50
1.25%
-6.45
Intuitive Surgical Inc stock is traded at $495.50, with a volume of 447.74K.
It is down -1.25% in the last 24 hours and down -5.24% over the past month.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$501.95
Open:
$503.52
24h Volume:
447.74K
Relative Volume:
0.27
Market Cap:
$177.51B
Revenue:
$9.15B
Net Income/Loss:
$2.61B
P/E Ratio:
69.11
EPS:
7.17
Net Cash Flow:
$1.75B
1W Performance:
-3.97%
1M Performance:
-5.24%
6M Performance:
-15.13%
1Y Performance:
+9.17%
1-Day Range:
$495.04
$505.74
1-Week Range:
$495.04
$523.09
52-Week Range:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
495.26 | 183.15B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.29 | 51.96B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
92.17 | 43.85B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
272.91 | 39.21B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
277.03 | 15.73B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Intuitive Surgical Sees Early Wins With Da Vinci 5, Lifts FY25 Guidance As Tariff Impact Eases - insights.citeline.com
Intuitive Surgical updates 2025 da Vinci procedure growth guidance to 15.5%-17% as da Vinci 5 launches expand - MSN
Intuitive Surgical’s Earnings Call: Growth Amid Challenges - TipRanks
Intuitive Surgical Inc. (ISRG) Surges to 25th in Trading Volume with $2.339 Billion in Shares Exchanged Despite Stock Price Decline - AInvest
Intuitive Surgical Exceeds Expectations with Strong Q2 Performan - GuruFocus
INTUITIVE SURGICAL INC SEC 10-Q Report - TradingView
Intuitive Surgical's Q2 2025 Earnings Surge: Is This the Start of a New Growth Cycle? - AInvest
Robotic Surgery Titan Yo-Yoes Despite 'Solid' Quarterly Report - Investor's Business Daily
Intuitive Surgical price target raised to $600 from $590 at Baird - TipRanks
What drives Intuitive Surgical Inc. stock priceHigh-impact stock picks - Autocar Professional
Intuitive Surgical (ISRG) Reports Strong Q2 Earnings With Revenue Up To US$2,440 Million - simplywall.st
Intuitive Surgical price target raised to $615 from $605 at RBC Capital - Investing.com Canada
Intuitive Surgical tempers tariff impact expectations - MedTech Dive
Bernstein raises Intuitive Surgical stock price target as da Vinci 5 enters broad launch - Investing.com India
Intuitive Surgical Skids As Robotic Surgery Giant Calls For A Slowdown This Year - MSN
Intuitive Surgical Crushes Q2 Expectations, So Why No Rally? - MarketBeat
ISRG: Wells Fargo Raises Intuitive Surgical Price Target to $599 - GuruFocus
Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True? - Yahoo.co
ISRG: Solid Numbers, Tariff Concerns - The Motley Fool
Intuitive Surgical (ISRG) Receives Downgrade Amid Profit Concern - GuruFocus
ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts - Yahoo.co
Intuitive Surgical (ISRG) Price Target Raised by RBC Capital | I - GuruFocus
Intuitive Q2 2025 revenue increases 21% to USD 2.44B - Medical Buyer
Intuitive Surgical down despite earnings beat on profit margin warning from tariffs - MSN
What analysts say about Intuitive Surgical Inc. stockFree Stock Market Trend Analysis - Autocar Professional
Intuitive Surgical (ISRG) Price Target Raised by UBS Amid Rising Adoption | ISRG Stock News - GuruFocus
Intuitive Surgical stock rises as Stifel reiterates Buy rating on DV5 launch - Investing.com Australia
Intuitive Surgical (ISRG) Sees Increased Price Target and Positive Outlook | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Price Target Raised by BTIG | ISRG Sto - GuruFocus
Intuitive Surgical price target raised to $571 from $566 at BTIG - Investing.com Australia
Raymond James reiterates Outperform rating on Intuitive Surgical stock - Investing.com Australia
Intuitive Surgical (ISRG) Reports Q2 Earnings: What Key Metrics Have to Say - MSN
Intuitive Surgical (ISRG) Price Target Increased by Wells Fargo - GuruFocus
Intuitive beats The Street in Q2 as da Vinci sales grow 17% - MassDevice
Intuitive Surgical’s Strong Q2 Performance and Strategic Expansions Justify Buy Rating - TipRanks
Intuitive Surgical’s Strong Financial Performance and Growth Prospects Justify Buy Rating - TipRanks
Intuitive Surgical’s Strong Q2 Performance and Strategic Moves Justify Buy Rating - TipRanks
Intuitive Surgical Exceeds Expectations As Robot Surgeries Climb - Finimize
Intuitive Surgical Inc (ISRG) Q2 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance
Intuitive Surgical Inc (ISRG) Q2 2025 Earnings Call Highlights: Robust Revenue Growth and ... By GuruFocus - Investing.com Canada
Baird raises Intuitive Surgical stock price target to $600 on strong growth - Investing.com
Piper Sandler raises Intuitive Surgical stock price target on strong Q2 - Investing.com
Intuitive Surgical Reports Strong Q2 2025 Earnings - TipRanks
Intuitive Surgical (ISRG) Q2 2025 Earnings Call Transcript - Fortune
Intuitive Surgical (ISRG) Reports Strong Q2 2025 Performance Dri - GuruFocus
Intuitive Surgical Inc. Surges to 70th in Trading Volume with $1.217 Billion in Shares Exchanged - AInvest
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots - TradingView
Intuitive Surgical (ISRG) Reports Strong Q2 Results, Exceeds Exp - GuruFocus
Intuitive Surgical (ISRG) Faces Margin Pressure Despite Q2 Succe - GuruFocus
Intuitive (ISRG) Q2 2025 Earnings Transcript - The Globe and Mail
Intuitive Surgical's Q2 2025 Outperformance: A Strategic Deep Dive into Robotic Surgery's Expanding Market Dominance - AInvest
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):